Skip to main content
v2026.11,858 entries · CC-BY 4.0
LAC HealthMedical & Research SuppliesReagents, PPE & instruments — chain-of-custody documented.Fast, traceable sourcing built for regulated research environments, from bench consumables to instrumentation.Shop lac.us CodeCASRAIlac.us

IUPHAR: Guide to Pharmacology, NC-IUPHAR, and Target Standards

An in-depth guide to IUPHAR, NC-IUPHAR receptor nomenclature, and the curated IUPHAR/BPS Guide to Pharmacology database for drug discovery researchers.

Written and maintained by CASRAI Editorial Board

Last updated

The International Union of Basic and Clinical Pharmacology (IUPHAR) is the global non-profit scientific organisation representing pharmacologists, clinical researchers, and drug discovery specialists worldwide. Established in 1959 as an independent scientific union, IUPHAR connects regional and national pharmacology societies to advance pharmacological science, foster international research collaboration, and establish rigorous global nomenclature standards.

For investigators entering drug discovery or exploring discipline boundaries, the guide to what is pharmacology details core experimental methods, funding mechanisms, and scientific competencies. Understanding the foundational distinctions between pharmacy vs pharmacology helps differentiate between patient-facing pharmaceutical care and laboratory drug mechanism evaluation.

What IUPHAR Is and Its Global Role

IUPHAR acts as the primary global voice for basic and clinical pharmacology. It operates under the International Science Council (ISC) and maintains official relations with the World Health Organization (WHO). IUPHAR’s overarching mission is to improve global human health by advancing drug research, establishing consensus classification for biological targets, encouraging ethical animal welfare in preclinical research, and sponsoring the quadrennial World Congress of Basic and Clinical Pharmacology (WCP).

In modern drug discovery pipelines, researchers frequently cross-reference functional chemical bioassays in repositories like the PubChem chemistry and bioassay repository with molecular target data in IUPHAR resources, and publish validated lead compounds in journals such as the Journal of Medicinal Chemistry or through national member societies such as ASPET.

Who Runs IUPHAR and the NC-IUPHAR Nomenclature Committee

IUPHAR is governed by an elected Executive Committee comprising the President, Past President, Secretary-General, Treasurer, and Vice-Presidents representing distinct global geographic regions. IUPHAR coordinates national member societies, specialized scientific sections (such as clinical pharmacology, drug metabolism, and neuropharmacology), and project committees.

The scientific cornerstone of IUPHAR is the Nomenclature and Standards Committee of IUPHAR (NC-IUPHAR). Initiated in 1987 at the Xth International Congress of Pharmacology and formally established in 1989 under the chairmanship of Paul Vanhoutte, NC-IUPHAR has been led by prominent pharmacologists including Robert Ruffolo (1998–2002), Michael Spedding (2002–2015), and Steve Alexander (2015–present). NC-IUPHAR operates over 30 specialized subcommittees comprising hundreds of international experts who oversee classification across major biological target families:

  • G Protein-Coupled Receptors (GPCRs): Subcommittees classify rhodopsin-like (Class A), secretin-like (Class B), glutamate-like (Class C), and adhesion GPCRs based on evolutionary phylogeny, sequence homology, and endogenous ligand pairing.
  • Voltage-Gated Ion Channels (VGICs): Organizes potassium, sodium, calcium, and cyclic nucleotide-regulated channels into unified structural gene families.
  • Ligand-Gated Ion Channels (LGICs): Categorizes nicotinic acetylcholine, GABA_A, glycine, 5-HT_3, ionotropic glutamate, and P2X receptors.
  • Nuclear Hormone Receptors: Classifies steroid, thyroid, retinoid, and orphan receptors by DNA-binding domain architecture and ligand responsiveness.
  • Kinases and Catalytic Receptors: Encompasses receptor tyrosine kinases, serine/threonine kinases, and receptor guanylyl cyclases.
  • Transporters and Enzymes: Curates solute carrier (SLC) families, ATP-binding cassette (ABC) efflux pumps, and drug-metabolizing enzymes.

NC-IUPHAR subcommittees publish authoritative nomenclature reviews and official guidelines in peer-reviewed literature, primarily within Pharmacological Reviews and the British Journal of Pharmacology, enforcing standards for peer-reviewed references and reproducible assay reporting.

The IUPHAR/BPS Guide to Pharmacology Database

To provide researchers with open digital access to expert-curated pharmacological data, IUPHAR partnered with the British Pharmacological Society (BPS) to develop the IUPHAR/BPS Guide to PHARMACOLOGY (abbreviated as GtoPdb, hosted at guidetopharmacology.org). GtoPdb serves as an authoritative, expert-curated “one-stop shop” portal detailing quantitative ligand-activity-target relationships.

The database evolved from the historical BPS Guide to Receptors and Channels (GRAC) into a dynamic online knowledgebase accompanied by the biennial Concise Guide to PHARMACOLOGY published in the British Journal of Pharmacology. GtoPdb provides curated coverage of all approved human drug targets, investigational compounds, and experimental tools. Records link directly to major bioinformatics resources including UniProt, Ensembl, ChEMBL, PubChem, DrugBank, and PubMed.

Research programs supported by federal granting initiatives such as the NIH Intramural Research Program frequently utilize GtoPdb target annotations to validate target druggability and identify selective chemical probes.

How to Search and Use the Guide to Pharmacology Database

Pharmacology and drug discovery researchers navigate GtoPdb using six core procedural steps:

  1. Access and User Registration: Navigate to guidetopharmacology.org. While the database is open access for academic and non-profit researchers under CC BY-SA 4.0 licensing, users complete a quick, free registration to access detailed curated views and help maintain database sustainability metrics.
  2. Target Family Hierarchy Search: Select the “Targets” menu to browse hierarchical classifications of GPCRs, Ion Channels, Nuclear Receptors, Kinases, Catalytic Receptors, Transporters, or Enzymes. Target family overview landing pages provide curated summaries of physiology, disease associations, and key selective agonists or antagonists.
  3. Ligand Identification and Chemical Search: Use the “Ligands” menu or keyword search bar to query synthetic small molecules, approved drugs, endogenous peptides, or natural products. Review curated ligand summary pages detailing IUPAC names, 2D chemical structures, SMILES strings, and quantitative binding affinities ($K_i$, $K_d$, $IC_{50}$, $EC_{50}$).
  4. BLAST Sequence Alignment: Utilize the integrated BLAST search tool under “Target search tools” to align novel protein or nucleotide sequences against curated pharmacological targets to identify homologous receptor families.
  5. Specialized Portal Exploration: Investigate targeted sub-portals including the Immuno-Pharmacology Portal (GtoImmuPdb) or the Malaria Portal for specialized disease pharmacology and therapeutic intervention pathways.
  6. Data Download and Web Services: Access structured batch data, full database dumps (PostgreSQL), and RESTful web service APIs via the “Downloads” tab for computational cheminformatics and systems pharmacology pipelines.

Strengths and Limits

Evaluating the practical role of IUPHAR and its curated database highlights several distinct strengths and structural limits:

  • Strengths: Expert-led manual curation by NC-IUPHAR committee members eliminates automated text-mining errors; strict verification of selective chemical tool compounds prevents misleading off-target pharmacological inferences; consensus receptor nomenclature provides universal scientific stability across literature; and open-access licensing permits broad academic reuse.
  • Limits: Because curation is manual and expert-driven, GtoPdb has a more selective scope than massive automated repositories like PubChem or ChEMBL; commercial organisations are required to pay annual sustainability access fees; and clinical prescribing protocols must be cross-checked with regional regulatory formularies.

Alternatives to the IUPHAR Database

Researchers in medicinal chemistry, pharmacology, and computational biology compare GtoPdb with other public chemical-biological databases:

Database Curating Institution Primary Focus Key Advantage
IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb) IUPHAR & British Pharmacological Society Curated ligand-target interactions and receptor nomenclature Manual peer-reviewed validation by NC-IUPHAR expert subcommittees; gold-standard selective tool compounds.
ChEMBL European Bioinformatics Institute (EMBL-EBI) Bioactive drug-like small molecules from literature Massive scale with millions of bioactivity data points suitable for large-scale machine learning models.
PubChem National Center for Biotechnology Information (NCBI) Comprehensive chemical substance and bioassay data repository Broadest coverage of chemical structures, high-throughput screening campaigns, and regulatory records.
DrugBank OMx Technologies / University of Alberta Comprehensive drug and drug-target database Detailed clinical pharmacology, drug metabolism mechanisms, and drug-drug interaction data.

Frequently Asked Questions

What does IUPHAR stand for?

IUPHAR stands for the International Union of Basic and Clinical Pharmacology, an international non-profit organisation representing pharmacologists and establishing global pharmacological standards.

What is NC-IUPHAR?

NC-IUPHAR is the Nomenclature and Standards Committee of IUPHAR. It operates more than 30 specialized subcommittees that issue definitive classification and nomenclature guidelines for biological receptors, ion channels, and drug targets.

Is the IUPHAR Guide to Pharmacology free to use?

Yes. The IUPHAR/BPS Guide to PHARMACOLOGY is freely accessible for academic, clinical, and non-profit research under a Creative Commons Attribution-ShareAlike 4.0 license, requiring only a simple free user registration.

How does GtoPdb differ from ChEMBL or PubChem?

GtoPdb is selectively curated by expert pharmacology committees focusing on validated receptor targets, quantitative pharmacological parameters, and selective tool compounds, whereas ChEMBL and PubChem are large-scale repositories aggregating automated and broad-screening data.

Sources

  • International Union of Basic and Clinical Pharmacology (IUPHAR). “Welcome to IUPHAR.” Official website, https://iuphar.org/ (Read 2026-11-07).
  • IUPHAR/BPS Guide to PHARMACOLOGY. “About The Guide to PHARMACOLOGY.” Official database portal, https://www.guidetopharmacology.org/about.jsp (Read 2026-11-07).
  • IUPHAR/BPS Guide to PHARMACOLOGY. “About NC-IUPHAR.” Official database portal, https://www.guidetopharmacology.org/nciuphar.jsp (Read 2026-11-07).
  • IUPHAR/BPS Guide to PHARMACOLOGY. “Help & FAQ: Database Access and Sustainability.” Official database portal, https://www.guidetopharmacology.org/faq.jsp (Read 2026-11-07).
  • Alexander, S. P. H., et al. “The Concise Guide to PHARMACOLOGY.” British Journal of Pharmacology, biennial database compendium (Read 2026-11-07).

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about IUPHAR: Guide to Pharmacology, NC-IUPHAR, and Target Standards

Ask your first 2 questions free below. Subscribers get 150 a day for $29 a month.

An AI assistant specialized in research administration. It cites the sources behind every answer, labels web answers and says when it can't answer.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays free to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →